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Spotted fever group rickettsiae are gram-
negative intracellular bacilli associated with
arthropods and transmitted by ticks. The most
common clinical features of rickettsioses in
humans are fever, headache, rash, and
inoculation eschar. Five well-characterized
and three recently proposed rickettsioses of
humans have been identified in the past 13 years.
Extensively studied rickettsioses include
Japanese spotted fever (caused by Rickettsia
japonica), Astrakhan fever (Astrakhan fever
rickettsia), Flinder’s Island spotted fever
(R. honei), California flea typhus (R. felis), and
African tick-bite fever (R. africae). In France,
R. conorii, the agent of Mediterranean spotted
fever, which is transmitted through the bite of
the brown dog tick (Rhipicephalus sanguineus),
is the main pathogenic rickettsia and is
encountered in the southern part of the country.
Recently, “Rickettsia mongolotimonae,” R. slovaca,
and  R. helvetica have also been identified as
agents of human rickettsioses in Europe. Other
species of unknown pathogenicity—including
R. rhipicephali, R. massiliae, and Bar 29—have
been isolated from ticks in Europe.
 R. helvetica has been isolated from Ixodes
ricinus collected in Switzerland, France, Slovenia,
and Sweden. These ticks, which readily bite
humans, are also the vectors in Europe of
Borrelia burgdorferi and  Ehrlichia
phagocytophila, the agent of human granulocytic
ehrlichiosis. I. ricinus is widely prevalent in parts
of Europe (1), including eastern France, and
frequently bites humans (Figure 1). Conse-
quently, the potential transmission of R. helvetica
by I. ricinus to humans seemed likely, but its
pathogenic capacity in this regard remained
uncertain until Nilsson et al. demonstrated its
role in the development of perimyocarditis and
sudden death in two young patients (2).
 In this report, we describe a human infectious
syndrome in which specific seroconversion
against R. helvetica occurred. We also present the
results of a serosurvey on rickettsioses conducted
in Alsace (eastern France) among forest workers,
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A 37-year-old man living in eastern France seroconverted to Rickettsia helvetica in
August 1997, 4 weeks after the onset of an unexplained febrile illness. Results of a
serosurvey of forest workers from the area where the patient lived showed a 9.2%
seroprevalence against R. helvetica. This organism may pose a threat for populations
exposed to Ixodes ricinus ticks.
Figure 1. Map of Europe showing the distribution of
Ixodes ricinus (1). The areas where I. ricinus is
prevalent are shaded in black and the prevalence of
R. helvetica in I. ricinus, where estimated, is indicated.Dispatches
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which showed high prevalence of antibody
reactive with this bacterium.
Case Report
A 37-year-old, immunocompetent man was
admitted to a hospital in Strasbourg, Alsace, on
August 18, 1997, with prolonged fever, fatigue,
myalgias, and headache of unknown etiology.
The fever had begun on August l, 18 days after
the man walked in a forest near Strasbourg,
where he observed numerous ticks but not any
tick bites. On physical examination, the
physician observed low-grade fever (38.1°C) but
no rash, lymphadenopathy or inoculation eschar.
 Results of laboratory tests included an
elevated C-reactive protein (48 mg/L); increased
fibrinogen level (6.0 g/L); accelerated erythrocyte
sedimentation rate (34 mm, first hour); leukocyte
count of 6,700/mm3; platelet count of 165,000/
mm3; and increased rates of alanine-aminotrans-
ferase (60 IU/L) and aspartate aminotransferase
(52 IU/L). Blood cultures taken on August 18
were negative. The patient received no antibiotic
treatment and recovered spontaneously within 2
weeks. Rickettsial serologic tests were performed
on serum samples (taken on days 17, 27, and 86
after onset) at the Unité des Rickettsies.
Antibody levels against B. burgdorferi, Francisella
tularensis, E. phagocytophila, and hepatitis A, B
and C viruses were measured in Strasbourg but
were negative.
Serosurvey
A convenience collection of serum samples
from 379 forest workers from Alsace, all of whom
were state employees, was obtained. These
samples had been initially collected as part of a
systematic serosurvey organized by the state
department of occupational medicine to evaluate
for the presence of antibodies to B. burgdorferi.
This population was composed of 377 men and 2
women, 20 to 59 years of age; 360 (95.5%)
reported frequent tick bites but were clinically
asymptomatic; the remaining 19 reported no tick
bites. No questionnaire was administered. After
informed consent from the patients, antibodies to
R. helvetica,  R. conorii,  R. slovaca, and
“R. mongolotimonae” were determined.
Serologic Tests
To determine the specificity of cross-
reactions, serum samples, including those from
the survey, were adsorbed with R. conorii,
R. helvetica,  R. slovaca or R. mongolotimonae
antigens. Cross-adsorption procedures were
performed (3). R. helvetica, R. conorii, R. slovaca,
and “R. mongolotimonae” Western blot analyses
were performed on the resultant supernatants.
Purified R. helvetica, R. conorii, R. slovaca, and
“R. mongolotimonae” were suspended in sterile
water and adjusted to 2 mg/mL with a UV
spectrophotometer. Western blotting procedures
using unheated antigens were performed (4).
Antibodies reacting against antigens of 20 to 50
kDa were assumed to be directed primarily
against the lipopolysaccharide in R. helvetica,
R. conorii, R. slovaca, and “R. mongolotimonae.”
Serologic specificity toward the different spotted
fever group rickettsia species was determined by
the relative immunoglobulin G (IgG) reactivity to
species-specific antigens in the 110- to 145-kDa
region. Intensity measures were compared by
video image acquisition (The Imager, Appligene,
Illkirch, France).
Case Findings
The first serum sample, taken from the
patient on August 18, was negative for all tested
antigens. Samples taken on August 27 and
October 27 yielded IgG titers of 1:128, 1:64, 1:128
and 1:256, and IgM titers of 1:64, 1:16, 1:32 and
1:128 against R. conorii,  R. slovaca,
“R. mongolotimonae,” and R. helvetica, respec-
tively, but were negative for Coxiella burnetii and
E. phagocytophila. Western immunoblotting of
the patient’s serum samples demonstrated cross-
reactivity between R. helvetica,  R. slovaca,
“R. mongolotimonae,” and  R. conorii antigens,
but adsorption with R. helvetica antigen
eliminated all antibodies. After adsorption with
R. conorii, R. slovaca, and “R. mongolotimonae”
antigens, antibodies to R. helvetica were still
present,  but antibodies to the other three
antigens were not observed, indicating that
R. helvetica was the etiologic agent.
Serosurvey Findings
Of the 379 patients included in our
serosurvey, 35 (9.2%) demonstrated anti-
R. helvetica IgG titers  1:64 (16 had an IgG titer of
1:64; 13 a titer of 1:128; 5 a titer of 1:256; and one
a titer of 1:512). IgM was not detected in any
patient. In all positive serum samples, titers were
greater against R. helvetica than against any of
the other three tested antigens by two or more
dilutions (Figure 1). Following adsorption withDispatches
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Figure 2. Antibody titers against Rickettsia helvetica,
R. conorii, R. slovaca, and “R. mongolotimonae” in 35
forest workers, Alsace.*
*Each diamond represents the IgG titer in serum samples
from the patients. R. conorii Moroccan strain (ATCC VR
141), R. helvetica C9P9 strain, R. slovaca 13-B strain, and
“R. mongolotimonae” HA91 strain were grown on confluent layers of Vero cells
in a 150-cm2 flask. Infection was monitored by Gimenez
staining. When 90% of the cells were infected, cell layers and
supernatants were harvested, pelleted by centrifugation
(10,000 x g for 10 min), and resuspended in 15 mL of
phosphate-buffered saline (PBS, pH 7.3). Antigen purifica-
tion was performed (5). The final suspension was
resuspended in sterile water, and the protein content of the
purified organisms was determined by UV spectrophotome-
try and adjusted to 1 mg/mL. All four rickettsial antigens
were applied by pen point to each well of 30-well microscope
slides (Dynatech Laboratories Ltd., Billingshurt, United
Kingdom), air dried, and fixed with acetone for 10 min. This
allowed a direct comparison of fluorescence intensity
between antigens. All serum samples, including positive and
negative controls, were diluted 1/4, 1/8, 1/16, 1/32, 1/64 and
1/128 in PBS with 3% nonfat dry milk. Microimmunofluores-
cence procedures were performed (3). All serum samples
found to be positive for total immunoglobulins were diluted
serially (twofold dilutions ranging from 1/32 to 1/2,048 or
more), and the titers of IgG and IgM were determined. Before
detection of IgM, serum was adsorbed with a rheumatoid
factor absorbent (RF-absorbent, Behring-werke AG, Mar-
burg, Germany). Titers at or above 1:64 for IgG or 1:32 for IgM
were considered positive.
R. helvetica antigen, all antibodies were
eliminated.
Conclusions
 Epidemiologic evidence suggests that our
patient was exposed to I. ricinus during his forest
walk. He did not report any tick bites, but larvae
or nymphs are often not detected by patients.
Clinically, he presented with a prolonged low-
grade fever, headache and myalgias. Unfortu-
nately, no blood specimen was available for
culture. Though neither cardiac symptoms nor a
rash developed, the latter is sometimes lacking in
other spotted fever group rickettsioses, such as
African tick-bite fever or R. slovaca infection.
The usual method for the diagnosis of
rickettsioses is serologic testing; the easiest
method is microimmunofluorescence. Although
serological cross-reactions are common among
spotted fever group rickettsiae (6), R. helvetica is
phylogenetically distant from other spotted fever
group rickettsiae as well as from typhus group
rickettsiae. Thus, one could expect the antibody
response to this bacterium to be higher than
against other spotted fever group rickettsiae. In
our patient and 35 (9.2%) of 379 tested forest
workers, antibody titers against R. helvetica were
higher than those detected against R. conorii,
R. slovaca, and “R. mongolotimonae.” The
specificity of the antibody response was
confirmed by cross-adsorption and Western
blotting. The forest workers lived in Alsace, an
area where R. conorii and Rhipicephalus sp. are
absent but where I. ricinus is highly prevalent,
and were frequently exposed to ticks. To date,
I. ricinus has only been demonstrated to harbor
one rickettsial species, R. helvetica. Therefore,
the observed seroprevalence was mainly or fully
caused by R. helvetica. Although none of the
forestry workers in our study reported any tick-
bite-related disease, such results suggest that
this occupational group may be exposed to the
bites of I. ricinus and to R. helvetica infection.
Prospective evaluation of ill patients and
molecular identification of the causative agents
need to be conducted.
Our data support the notions that this
rickettsia, found in ticks (I. ricinus) that bite
humans and are widely distributed in forest
areas in Central Europe, could be frequent and
that  I. ricinus should be considered in the
diagnosis of tick-transmitted infection in Europe.
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